DELCOBESE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Delcobese, and when can generic versions of Delcobese launch?
Delcobese is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in DELCOBESE is amphetamine adipate; amphetamine sulfate; dextroamphetamine adipate; dextroamphetamine sulfate. There are fifty-five drug master file entries for this compound. Additional details are available on the amphetamine adipate; amphetamine sulfate; dextroamphetamine adipate; dextroamphetamine sulfate profile page.
Summary for DELCOBESE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 6,476 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DELCOBESE at DailyMed |